There are six sections to this survey, introduction, demographics, current practice, awareness, adoption/implementation and barriers.
Please read through each survey question with the following elements in mind—
Consistency: Question made sense, logical possible responses.
Navigation: Easy to move through survey, any technical difficulties.
Text: Easy to read.
Other: Comments and/or suggestions for how to improve the question (e.g., there was not an answer that fit my laboratory, too few or too many responses).
If you have no comments on the question, please write “no comment” in the “Other” box.
If there are more questions fields on the form than you answered, disregard them.
Keep track of how many minutes it takes you to complete the survey (not the collection form).
Question |
Elements |
Specific Observations |
|
||
|
||
|
||
|
||
|
How
many minutes did it take you to complete the Introduction section
(not the collection form)? _5 mins, 2 mins, 2 mins, 5 mins,
skipped__
SECTION II: DEMOGRAPHICS
Question |
Elements |
Specific Observations |
|
|
|||
|
Consistency |
|
|
Navigation |
|
||
Text |
|
||
Other |
-Not really a teaching institution but not state or county owned – confusing no option appropriate. -Maybe wrong question.
|
||
|
|||
|
|||
Other |
-Assume you mean Pathologists -Information not readily available, Duckworth Pathology Group & Residents |
||
|
|||
|
|||
|
|||
|
|||
|
|||
Other |
-This hospital has ~400 beds, but for the system it is >500 beds & we do all the micro excluding pediatrics
|
||
|
|||
|
|||
|
|||
|
|||
Other |
-Dr. Baselski is our clinical consultant with Duckworth Pathology Group, she acts as our “clinical microbiologist” extraordinaire, but does not have the laboratory director title. |
||
ABP (American Board of Pathology) Sub-boarded in Medical Microbiology
D(ABMM)
Diplomate, American Board of Medical Microbiology D(ABB)
Diplomate, American Board of Bioanalysis, HCLD (High Complexity
Laboratory Director) |
How
many minutes did it take you to complete the Demographics section
(not the collection form)? _5 mins, 6 mins, 2 mins, 15 mins,
skipped_
SECTION III: CURRENT PRACTICE
Question |
Elements |
Specific Observations |
|
|
|||
Other |
-May need more choices to describe when collection w.IV catheter allowed (ex: patient hard to stick, patient refuses to be stuck again) |
||
|
|||
Other |
-This number is an educated guess, did not have this data for 2013. |
||
|
|||
|
|||
Other |
-May need more choices to describe when collection with IV catheter allowed- (E4- patient hard to stick, patient refuses to be stuck again) -Dept works them up but doesn’t make policy |
||
|
|||
American Society for Microbiology Clinical and Laboratory Standards Institute Centers for Disease Control and Prevention Laboratory Medicine Best Practices Other (please insert name here) ___________________ |
|||
Other |
Our hospital uses NHSN guideline, it might be helpful to include that as part of CDC choice |
||
|
|||
|
|||
|
|||
|
|||
|
|||
Other |
‘In general’ makes question seem a little vague |
||
American
Society for Microbiology |
|||
Other |
-Guess because IDSA is what we follow for line infections |
||
Infectious Disease Society of America American
Society for Microbiology |
|||
Other |
I do not know the specific guidelines followed (which group). |
||
|
|||
Consistency |
Didn’t know there were pre-packaged kits – what is included? |
||
Other |
Phlembotomy uses, line draws by nurses unknown |
||
|
|||
Consistency |
Might be helpful to designate ‘laboratory’ phlebotomists |
||
Other |
Many line draws in units – nursing (RNs, LPNs, EMTs, Paramedics) draw all lab in the ED |
||
|
|||
|
|||
|
|||
Other |
-I think yearly for nursing, phlebotomy would follow CAP requirements -Choices for “how often” I think would be helpful |
||
|
How
many minutes did it take you to complete the Current Practice section
(not the collection form)? _30 mins, 20 mins, 5 mins, 10 mins,
skipped_
SECTION IV: AWARENESS
|
|
Other |
Dept works them up but doesn’t make policy I copied the reference & will read it. I’m sure Dr. Baselski already has. |
-Direct communication from colleague -Professional organization publications (e.g. Practical Guidance for Clinical Microbiology [formerly Cumitechs], Clinical Microbiology Procedures Handbook) -Electronic communication via listserv, social media, newsletters -Lab Medicine Best Practices website or other internet website -PubMed or journal -Professional Meeting or Conference -Attendance at regional meetings -Webinars/webcasts or other training -Other, please specify: |
|
40 Check
all statements that are accurate: -I skimmed parts of the abstract or manuscript. -I
did not read it yet, but I plan to. |
|
|
|
|
|
|
|
|
|
|
|
46. Are there other ways you prefer to receive information on new laboratory guidelines and recommendations? |
How
many minutes did it take you to complete the Awareness section (not
the collection form)? 15 mins, 8 mins, 5 mins, 5 mins, skipped_
SECTION V: ADOPTION/IMPLEMENTATION
|
|
Other |
-No response really applicable if you have not seen publication -Dept works them up but doesn’t make policy -Plenty of choices in #45 |
|
|
|
|
50 Except for diagnosing IV catheter infection, has your laboratory stopped collecting blood? Yes/No |
|
|
|
Other |
If you have not read publication, not sure exactly what is meant by ‘phlebotomy team’ |
|
|
Other |
-I feel this question is hard to answer if you haven’t read the publication. -Question asks why, but lists classes of patients. |
How
many minutes did it take you to complete the Adoption/Implementation
section (not the collection form)? 6 mins, 5 mins, 5 mins_
SECTION
VI: BARRIERS
53. Are there barriers to implementation of the recommendations in your laboratory? Yes/No |
|
Consistency |
Cannot answer if you don’t know what specific recommendations are. |
Other |
-Dept works them up but doesn’t
make policy
|
54.
What are they? |
|
Other |
-Maybe don’t need to answer last 5 questions if you have not read the publications. -I am not sure exactly which ones apply. I am assuming it is primarily because on satisfaction survey patient complain about being stuck. |
55. Are there any other blood culture contamination methods purported to reduce blood culture contamination that we need to evaluate in future updates of this publication? |
|
56. What can ASM and/or CDC do to help remove barriers and make it easier to implement the recommendations/guideline? |
How
many minutes did it take you to complete the Barriers section (not
the collection form)? 4 mins, 5 mins, 5 mins, 2 skipped_
OVERALL SURVEY EVALUATION |
Strongly Disagree |
Disagree |
Neutral |
Agree |
Strongly Agree |
|
(Place an “X” to indicate your level of agreement for each statement below). |
1 |
2 |
3 |
4 |
5 |
|
57. The survey questions are easy to understand. |
|
|
|
3 |
2 |
|
58. I was always able to find an appropriate answer to choose. |
|
1 |
1 |
4 |
|
|
59. The answer choices are clearly written. |
|
|
|
3 |
1 |
|
60. There were not enough choices of answers. |
|
1 |
4 |
|
|
|
61. I always found the answer that fit the circumstances in my laboratory. |
|
1 |
2 |
2 |
|
|
|
||||||
62. Overall, the length of the survey was… (circle your answer) |
||||||
too short |
appropriate (4) |
too long (1) |
||||
63. What did you like best about the survey (strengths, weaknesses)? -I think it is very important to reduce blood culture contamination. I’m sure the publication “Effectiveness of Practices to Reduce Blood Culture Contamination: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis” would be very helpful, but last part of survey was difficult to answer if you have not read it. -Needs to be more clear -> when you are a laboratory for a large healthcare system – how to answer the questions. Do you answer for the facility where the lab resides or for all the hospitals that it serves? -It made me want to do more research.
|
||||||
64. Additional thoughts/comments: -At some point after question 38 of the IV Awareness section, since I had not read the publication, I lost tract of switching to section V: Adoption/ Implementation and Section VI: Barriers. I just answered in numerical order under IV: Awareness section. -Easily navigated; easy to read -I felt ill-equipped to answer most
|
Return your completed form to Peggy McNult by email, [email protected] or fax (202) 942-9353 by December 22.
Thank you for your time and input!
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | Red Blood Cell Morphology Pilot Test |
Author | OWCD/TSD |
File Modified | 0000-00-00 |
File Created | 2021-01-20 |